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Abstract
Objective
Adolescent obesity is difficult to treat and the optimal dietary pattern, particularly in relation
to macronutrient composition, remains controversial. This study tested the effect of two
structured diets with differing macronutrient composition versus control, on weight, body
composition and metabolic parameters in obese adolescents.
Design
A randomized controlled trial conducted in a children’s hospital.
Methods
Eighty seven obese youth (means: age 13.6 years, BMI z-score 2.2, waist: height ratio 0.65,
69% female) completed a psychological preparedness program and were then randomized
to a short term ‘structured modified carbohydrate’ (SMC, 35% carbohydrate; 30% protein;
35% fat, n = 37) or a ‘structured low fat’ (SLF, 55% carbohydrate; 20% protein; 25% fat, n =
36) or a wait listed control group (n = 14). Anthropometric, body composition and biochemi-
cal parameters were measured at randomization and after 12 weeks, and analyzed under
the intention to treat principle using analysis of variance models.
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Results
After 12 weeks, data was collected from 79 (91%) participants. BMI z-scores were signifi-
cantly lower in both intervention groups compared to control after adjusting for baseline val-
ues, SLF vs. control, mean difference = -0.13 (95%CI = -0.18, -0.07), P<0.001; SMC vs.
control, -0.14 (-0.19, -0.09), P<0.001, but there was no difference between the two interven-
tion diet groups: SLF vs. SMC, 0.00 (-0.05, 0.04), P = 0.83.
Conclusions
Both dietary patterns resulted in similar changes in weight, body composition and metabolic
improvements compared to control. The use of a structured eating system which allows flex-
ibility but limited choices can assist in weight change and the rigid application of a low fat
eating pattern is not exclusive in its efficacy.
Trial Registration
International Clinical Trials Registry ISRCTN49438757
Introduction
Obesity in children and adolescents is of particular concern given the high prevalence world-
wide and the concomitant increased risk of developing comorbidities including cardiovascular
diseases (CVD) and diabetes [1]. It has been previously shown that the risk of a CVD event in
adulthood was significantly higher for every 1 unit increase in body mass index (BMI) z-score
for 7–13 year old children [2]. Therefore, it would seem that modest decreases in childhood
BMI could be an effective secondary prevention strategy for CVD [3]. At the most basic level,
reductions in BMI can be achieved by being in sustained negative energy balance (i.e. reduction
in energy intake and/or increased energy expenditure). However recent Cochrane reviews [4,
5] for the treatment of paediatric obesity demonstrate the relative lack of evidence for effective
treatment, particularly in children 12 years and older and emphasised the need for research
that assesses the effectiveness of dietary interventions on responsive outcomes such as weight
and lipid profile.
A dietary pattern low in fat (25–30% energy) is recommended internationally as a way to
minimise CVD risk, and is aligned with dietary guidelines that enable choice across a wide vari-
ety of foods. A systematic review across 30 countries robustly demonstrates that dietary fat
intake in children and adolescents are not aligned with recommendations [6]. Population
health surveys in the US and UK, that include children>2 years of age report dietary fat intake
around 34–36% of total energy intake [7, 8]. In Australian national surveillance data collected
in 2011–12 using a single 24 hour recall, reported dietary fat in 9–13 and 14–18 years olds was
31.4% and 31.8%, respectively [9]. In order to further guide the population, Australia provides
a proportional range of fat intake for children>2 years of age, the lower level of 20% and
upper acceptable level of 35% of energy intake [10]. Thus reducing consumption of dietary fat
to align with dietary guidelines is an obvious target for a weight and cardiovascular risk reduc-
tion strategy.
Carbohydrate intake has been a target for weight reduction programs as it is the largest pro-
portional contributor to overall energy intake (48–54%) in children and adolescents [8, 9].
Strategies that have been tried in adults include very low carbohydrate diets which have proved
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to be efficacious, despite initial scepticism that a higher fat content would adversely affect lipid
profile [11]. A recent meta-analysis comparing low fat versus very low carbohydrate diets in
adults concluded that low carbohydrate approaches may be equally, if not more effective, in
reducing weight and cardiovascular risk parameters after twelve months [12]. To date, most of
the low carbohydrate approaches tested have at least initial periods of severe restriction (20-
50g/day) resulting in ketosis. A study in 12–18 year olds reported similar findings, with a very
low carbohydrate (20g/day), high protein (2–2.5g protein/kg ideal body weight/day) diet com-
pared to a low fat (30% energy) diet being superior in terms of weight loss, safety and efficacy
after 13 weeks [13]. In younger children (7–12 years), modification of dietary carbohydrate
was as effective as ‘standard care’ (50–55% CHO, 10–15% protein, 30% fat) in terms of weight
loss [14]. However, following a very low carbohydrate unrestricted protein diet which induced
ketosis was difficult for the children to adhere to, compared to a low glycaemic index carbohy-
drate dietary pattern and therefore not a sustainable strategy to be promoted at a public health
level [14].
Dietary protein needs to be taken into consideration and obviously alters proportionally in
line with changes in other macronutrients. Ervin and Ogden [8] reported a rise in dietary pro-
tein in the US (boys to 14.7% and 14.3% for girls) in 2010, which was slightly less than Austra-
lian children who consume between 16–17% protein [9]. Gosby’s et al. (2014) systematic
review demonstrated that a relationship exists between higher protein intakes with lower
energy intakes in individuals aged 17–80 years, suggestive that if we derive more protein in our
diets it will help weight control longer term [15]. There is also some evidence across the life-
span that loss of lean tissue could be minimized by a higher protein intake during a weight loss
attempt [16].
The ‘low fat’ regimen was based on the proportional macronutrient composition between
the lower and upper acceptable ranges of macronutrients as defined by the Australian guide-
lines [10]. We hypothesized that a modest reduction in carbohydrate combined with a greater
protein intake could provide an optimal combination of macronutrients to our target group
and that either dietary pattern had potential to be adopted at a public health level. This
approach was tested in a ‘proof of concept’ phase that demonstrated the acceptability of using a
very structured food exchange menu approach alongside a lowering of carbohydrate to 35%
energy [17]. This test phase additionally highlighted that the adolescents presenting at a tertiary
hospital were unwilling or unable to engage in physical activity of sufficient intensity or dura-
tion to induce weight loss. Therefore, we aimed to compare the impact on weight of two differ-
ent macronutrient dietary patterns and the short term effect on a range of biochemical
parameters compared to an untreated control group. We test two hypotheses (1) there will be a
change in BMI z-score between the intervention diets and control; and (2) there will be a
change in mean BMI z-score between the low fat and the reduced carbohydrate group. Recog-
nising the many adverse psychological effects of childhood obesity [18], completion of a formal
psychological preparatory group program was a necessary initial step so that all participants
were in good psychological health, and similarly prepared for lifestyle change.
Materials and Methods
This randomized controlled trial took place at a tertiary children’s hospital in Brisbane, Austra-
lia. The ‘Eat Smart’ protocol has been published in full (see S1 Text) [19]. The study was con-
ducted according to the guidelines laid down in the Declaration of Helsinki and all procedures
involving human subjects were approved by the Royal Children’s Hospital & Health Service
District Ethics Committee (05/02/2008; #2008/005) that included the inclusion of a wait listed
control. Written informed consent was obtained from all parents/guardians and assent by their
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child. The ‘Eat Smart’ study is registered with the International Clinical Trials Registry
(ISRCTN49438757; http://apps.who.int/trialsearch/). Recruitment commenced three months
prior to registration due to administrative delays in payment processing. A CONSORT 2010
checklist for this trial is presented in S1 Table. The authors confirm that all ongoing and related
trials for this intervention are registered.
Eligibility
Participants were recruited after referral from a health professional and were initially screened
via telephone. Inclusion criteria: participants aged 10–17 years with a BMI>90th percentile, as
defined by Centre for Disease Control growth charts (CDC 2000) [20]. The World Health
Organisation defines adolescent development as between 10–19 years. In the tertiary hospital
sector in Australia, adolescents are seen until the age of 17 then moved to adult hospital. These
factors drove our inclusion age range. Exclusion criteria were use of stimulants or psychotropic
drugs known to alter body composition or metabolism including insulin sensitisers (eg. Bigua-
nides such as metformin), glucocorticoids and thyroxin. Those with obesity related to a medi-
cal condition (eg. Prader Willi Syndrome) and those with Type 1 diabetes or complex food
allergies were excluded. After completing a six week preparatory phase (FRIENDS for lifeTM
program [21]), all participants completed the Anxiety Disorder Interview Schedule (ADIS)
with a set of additional short questions on eating disorder behaviours in a one to one interview
with a clinical psychologist. In the event that the psychological interview suggested the pres-
ence of significant or clinically relevant levels of anxiety, depression, dysthymia, or other men-
tal health co-morbidity, participants were excluded from further participation and referred for
clinical psychological services. The ADIS interview was repeated at the end of the dietary inter-
vention phase (after week 12) to ensure that no psychological harm was induced by taking part
in the study protocol.
At baseline (week 0), all participants attended the hospital after an overnight fast, they were
weighed (kg) and measured (height to the nearest complete mm) and BMI z-score calculated
by the LMS method [22]. Blood pressure was measured using an automatic blood pressure
device (Vital Signs Monitor—Model No. 53N00, Welch Allyn, New York), 3 measures were
taken with the first measure being discarded to account for any initial patient discomfort (as
per laboratory protocol) and the remaining two readings were averaged. After a single blood
draw, samples were assayed for liver function, lipid profiles, insulin and glucose by automated
Clinical Chemistry Analyser (Unicel1DxC 800, Beckman Coulter, Inc., CA). Leptin, resistin,
adiponectin, plasminogen activator inhibitor-1 (PAI-1) and soluble ICAM-1 were measured in
duplicate using an in-house multiplex immunoassay 16 [23]; TNF-alpha and IL6 were mea-
sured using a high sensitivity Milliplex Kit (Millipore) and high sensitivity CRP was measured
by immunonephelometry using Siemens Cardiophase hsCRP reagent and measured on a Sie-
mens BNII instrument. Resting energy expenditure (REE) was measured using a ventilated
hood calorimeter (Deltratrac II Metabolic Monitor, Datex-Engstrom Division, Helsinki, Fin-
land), which was calibrated with a reference gas mixture of 95.00% O2 and 5.00% CO2. Oxygen
consumption and carbon dioxide production was measured at one minute intervals for 30 min-
utes and averaged over the whole measurement period. The subjects were required to rest in a
supine position for 20 minutes prior to the commencement of the test. The first five to ten min-
utes were excluded from the analysis to account for environmental adjustment by the subjects
and gas adaptation in the hood. REE was calculated from the measured oxygen consumption
and carbon dioxide production according to the formula by Weir [24]. A 4-day self-reported
activity diary based on one described by Bouchard et al. (1983) was used to derive physical
activity level (PAL), which divided a 24 hour day into 96 x 15 minute intervals and subjects
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were asked to record their activities during each time period [25]. On completion, each activity
was categorised into nine levels according to their average energy costs, representing multiples
of their respective metabolic equivalents (METs) and total daily METs values were calculated
and averaged to give an estimated PAL [26]. Thus an individual’s total energy expenditure was
estimated using the formula: EE = REE x PAL [27]. Lean cell mass was assessed using total
body potassium (TBK) and this was converted to z-scores to adjust for age and height [28].
Bioelectrical impedance analysis (Bodystat 1500MDD) was used to estimate body fat. All out-
comes measured at randomization (week 0) and at the end of the study period (week 12).
Demographic variables were recorded including ethnicity via a questionnaire administered
to the parent, which offered the following categories; Caucasian, Asian, South Sea Islander,
Aboriginal, Torres Strait Islander, Chinese or any other ethnic group. Social advantage was
determined using the Australian Bureau of Statistics Socio-Economic Index for Areas measure
of disadvantage. Each area represented by a postcode is ranked from most disadvantaged to
least disadvantaged in terms of the economic and social wellbeing of the residents in that area
[29]. We report social advantage after categorisation into tertiles.
Interventions
The intervention comprised of an intensive treatment phase with the study dieticians providing
five face-to-face counselling sessions for the subject and their carer (week 0,2,4,8 and 12) and
two via telephone (weeks 6 and 10). Standardized manuals ensured the sessions followed a pre-
determined path and used a client-centred approach with goal setting, problem solving and
self-monitoring techniques. Each subject was given an individualized energy prescription
based on a 20% energy reduction when compared to their estimated energy expenditure. A full
description of the intervention delivered has been reported [19] and relied on a similar struc-
tured meal approach with a plate portion system (TEMPlate™) guiding portion size at main
meals and an exchange system for other eating occasions. The plate templates had the appro-
priate size sections for the “structured low fat” (SLF, 55% carbohydrate, 20% protein, 25% fat)
and the “structured modified carbohydrate” (SMC, 35% carbohydrate; 30% protein; 35% fat)
to enable the desired macronutrient composition of the meal to be achieved. Controls were not
provided with any dietary advice; however, they were offered the dietary program of their
choice at the end of the study.
All groups received the Australian National Health and Medical Research Councils ‘Get out
and get active’ booklet [30]. They were encouraged to set a goal to decrease sedentary behav-
iour. No formal exercise or activity was prescribed. Retention strategies included flexible
appointment times, day-before text message appointment reminders and covering the cost of
parking at the hospital.
The primary outcome variable was reduction of BMI z-score after 12 weeks of dietary inter-
vention. Due to ethical considerations of withholding a potential treatment to a vulnerable con-
trol group, an unbalanced ratio of intervention and control was adopted with the allocation
schedule weighted so that participants would be enrolled in an active diet group 82% of the
time. Participants were allocated to treatment group using weighted randomisation, so that
they were allocated to the group that minimized the gender/pubertal stage imbalance between
groups with a probability of 0.8. If participants were not allocated to the group that minimized
the imbalance, they were randomly assigned one of the two remaining treatment groups with
equal probability. Allocation was conducted by the study statistician (RSW). Participants were
informed of treatment group at their baseline appointment. Families, who were allocated to an
active group, saw the study dietician (KAB) immediately. Due to the nature of the intervention,
participant blinding to group allocation was not feasible.
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Sample Size
Sample size calculations were informed by a pilot study conducted by the same research team
[17]. In the pilot study two diet intervention groups (low fat and modified carbohydrate) were
followed for 12 weeks. At study completion the mean (standard deviation; SD) changes in BMI
z-score were -0.20 (0.17) for the low fat group and -0.11 (0.08) for the modified carbohydrate
group. In order to observe a clinically important difference in BMI z-score change between the
two intervention groups of 0.09, with α = 0.05 and power of 80%, and assuming standard devi-
ation of 0.12 (the overall SD from the pilot study), we required 29 individuals in each interven-
tion group to complete the study. We calculated that if 12 week data was available on 12
participants from the control group, the study would have 80% power to detect a difference of
change in BMI z-score of 0.13 between the control group and either of the diet intervention
groups (α = 0.05). The difference of 0.13 was selected based on data extracted from a Cochrane
Review of lifestyle interventions in obese adolescents and represents a clinically important
change in BMI Z-score in this population. Based on these calculations we required 12 week
data from 70 participants (29 in each of the low fat and modified carbohydrate groups and 12
in the control group). We assumed we would not be able to collect 12 week data from 20% of
participants who began the study due to drop out (in pilot study 17% of participants dropped-
out), and consequently intended to enrol 85 participants (35 in each of the low fat and modified
carbohydrate groups, and 15 in the control group).
Statistical methods
All analyses utilized the intention-to-treat approach, with participants analyzed in the group
they were allocated to regardless of treatment compliance. Outcome variables are summarized
using mean (standard deviation; SD) for continuous variables and n (%) for categorical vari-
ables. The distribution of variables was investigated, and where appropriate variables were
transformed using the natural logarithm. Baseline characteristics were compared between the
three diet groups by either a one-way analysis of variance with diet group as the single factor
(continuous data) or Fisher’s Exact Test (categorical data). To compare the association between
diet group and outcomes at the end of the intervention, we used an analysis of variance model
with two factors: diet group and the outcome variable value at baseline. We included the value
of the outcome variable at baseline to adjust for possible imbalances between diet groups. We
tested the sensitivity of our results to missing data by using multiple imputation for the primary
outcome. BMI z-score values were imputed conditional on the explanatory variables (age, gen-
der, diet group, pubertal stage, and social position) using the Gaussian normal regression
imputation method. Twenty data sets were imputed. These analyses were pre-specified. To fur-
ther investigate our findings we conducted post-hoc analyses which considered the change
from baseline to end of intervention within each of the three diet groups. We tested within-
group change using Student’s t-distribution. Results of analyses are presented as mean differ-
ence (MD) and 95% confidence intervals (95%CI). A p-value of 0.017 was considered to indi-
cate statistical significance (accounting for Bonferroni correction of the three pair-wise diet
group comparisons). All analyses were conducted using Stata statistical software v. 11.1 (Stata-
Corp, College Station, TX, USA).
Results
Participants were recruited continuously from February 2008 to October 2012, with follow-up
completed by May 2013. A CONSORT flow chart of the study is shown in Fig 1. Of the 87 ran-
domized, 79 (91%) children were successfully followed-up at 12 weeks.
Macronutrient Composition andWeight Change in Obese Adolescents
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Participants followed-up were similar to those who dropped-out in terms of age and gender
(for those followed-up, 28% were male and mean (SD) age was 13.2 (2.0) years; for drop-outs,
Fig 1. Recruitment and follow-up of study participants.
doi:10.1371/journal.pone.0151787.g001
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25% were male and mean (SD) age was 13.6 (2.0) years; p = 1.00 for gender; p = 0.64 for age).
Demographic, social and biochemical characteristics at baseline are presented in Table 1. Of
particular note is the low body cell mass at baseline of participants as measured by TBK sugges-
tive of sarcopenia visually masked by body fat.
After 12 weeks of energy restriction, the mean (SD) BMI z-scores of the control, SLF and
SMC groups were 2.29 (0.42), 2.10 (0.46) and 2.05 (0.41) respectively (Table 2). After adjusting
for baseline BMI z-scores, there was no significant difference at the end of intervention between
BMI z-scores in the SLF and SMC groups, MD (95% CI) = 0.00 (-0.05, 0.04) p = 0.83; but there
was a significant difference between both the SLF and control (-0.13 (-0.18, -0.07) p<0.001)
and SMC and control (-0.14 (-0.19, -0.09) p<0.001) diet groups. When a sensitivity analysis
was undertaken on the primary outcome, BMI z-score, the effect estimates for BMI z-score did
not change substantively for any of the three pairwise comparisons: SLF vs. SMC, MD (95%
CI) = -0.01 (-0.06, 0.03), p = 0.57; SLF vs. control, -0.12 (-0.18, -0.06), p<0.001; SMC vs. con-
trol, -0.14 (-0.20, -0.08), p<0.001. Similar patterns of results were observed for the outcomes
weight z-score, BMI, weight, waist circumference and waist:height ratio, where a non-signifi-
cant difference was observed between the SLF and SMC groups, but a statistically significant
difference existed between the control diet group and each of the intervention diet groups.
Change from baseline to end of intervention within diet groups for anthropometric and body
composition measures are displayed in S2 Table. For the outcomes BMI z-score and weight z-
score, we observed statistically significant decreases in the SLF and SMC groups (all P<0.001),
whereas we observed a slight increase in the control group. Similar findings hold for BMI,
weight, waist circumference and waist:height ratio.
There were a number of differences in biochemical parameters evident between the control
and intervention groups (Table 3). Insulin resistance (HOMA-IR) was reduced in both inter-
vention groups and was statistically different from the control group. Both SLF and SMC
groups emerged with significantly lower leptin levels than the control group. Change from
baseline to end of intervention within diet groups for biochemistry and energy expenditure
measures are displayed in S3 Table.
Diet changes are described in Table 2. At randomization, there were no significant differ-
ences in macronutrient content of the diets between groups (mean %energy: carbohydrate
47%, protein 22%, fat 34%) and after 12 weeks the SLF group had significantly reduced their fat
intake by 4%, the SMC group had a significant decrease in carbohydrate by 9% and significant
increase in protein by 7%. There were no statistically significant differences pre- and post-
intervention in activity measures (overall PAL, hours of screen time and hours of sedentary
behaviour) between or within groups.
At baseline 16/87 (18%) participants met the criteria International Diabetes Federation defi-
nition for the Metabolic Syndrome21, this had reduced to 8/79 (10%) completers (with no sig-
nificant group differences). Hypertension remained present in 1 (7%) control, 6 (19%) SLF and
5 (15%) in the SMC group.
No physical adverse events were reported. No significant change in psychological parame-
ters was demonstrated via the ADIS interviews.
Discussion
Our findings demonstrate that a both the SLF and a SMC diet have the same short term bene-
fits in terms of weight loss, body composition change and lipid profile, and both are better than
not intervening. This challenges the current practice of only recommending a low fat/higher
carbohydrate diet for treatment of childhood obesity. The intensive nature of the ‘Eat Smart’
protocol was designed to have the maximum impact in a short time frame. Thus these results
Macronutrient Composition andWeight Change in Obese Adolescents
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Table 1. Demographic, social and biochemical characteristics of participants at baseline (n = 87).a,b
Control SLF SMC P-value
(n = 14) (n = 36) (n = 37)
Age, years 13.6 (1.9) 13.2 (2.1) 13.2 (1.9) 0.83
Female Gender 10 (71%) 26 (72%) 27 (73%) 1.00
Tanner stage
I 1 (7%) 5 (14%) 4 (11%) 0.96
II 4 (29%) 7 (19%) 8 (22%)
III 1 (7%) 6 (17%) 8 (22%)
IV 4 (29%) 7 (19%) 8 (22%)
V 4 (29%) 11 (31%) 9 (24%)
Ethnicity
Caucasian 10 (71%) 34 (94%) 33 (89%) 0.07
SE Asian 0 (0%) 1 (3%) 1 (3%)
Aboriginal & Torres strait Islander/Paciﬁc Islander 4 (29%) 1 (3%) 3 (8%)
Social Advantage
Lower-tertile 2 (14%) 7 (19%) 9 (24%) 0.57
Middle tertile 5 (36%) 14 (39%) 8 (22%)
Upper tertile 7 (50%) 15 (42%) 20 (54%)
BMI z-score 2.27 (0.43) 2.19 (0.39) 2.20(0.37) 0.78
Weight z-score 2.50 (0.76) 2.41(0.66) 2.43(0.53) 0.88
Height z-score 0.85 (0.87) 0.95 (1.07) 1.01 (1.02) 0.89
BCM/Height z-score -0.47 (0.85) -0.69 (0.92) -0.31 (1.21) 0.30
% body fat (using BIA) 40.36 (5.31) 39.67 (6.38) 38.61 (4.55) 0.54
BMI (kg/m2) 35.17 (8.54) 32.62 (5.9) 32.47 (4.90) 0.33
Weight (kg) 94.42 (30.94) 86.63 (22.60) 86.23 (18.18) 0.48
Height (cm) 162.46 (8.83) 161.93 (11.21) 162.38 (11.34) 0.98
Waist circumference (cm) 112.44 (19.27) 105.30 (13.53) 104.99 (11.84) 0.20
Waist:Height ratio 0.69 (0.10) 0.65 (0.07) 0.65 (0.07) 0.18
Hypertension present 4 (29%) 5 (15%) 9 (24%) 0.46
HOMA-IR 2.5 (2.1) 1.7 (1.0) 1.8 (0.9) 0.08
Cholesterol
Total (mmol/L) 4.5 (1.0) 4.4 (0.7) 4.4 (1.0) 0.90
HDL (mmol/L) 1.0 (0.3) 1.1 (0.2) 1.0 (0.2) 0.61
LDL (mmol/L) 2.9 (0.9) 2.8 (0.7) 2.7 (0.8) 0.84
VLDL (mmol/L) 0.6 (0.2) 0.5 (0.2) 0.6 (0.4) 0.47
Triglycerides (mmol/L) 1.3 (0.5) 1.2 (0.5) 1.4 (1.0) 0.53
Liver function
ALT (U/L) 34.5 (31.3) 30.4 (22.5) 28.3 (21.6) 0.72
Adipokines/cytokinesc
Leptin (ng/mL) 3.9 (0.6) 3.9 (0.6) 3.8 (0.5) 0.77
Resistin (ng/mL) 2.3 (0.5) 2.2 (0.4) 2.1 (0.4) 0.51
Adiponectin (ng/mL) 2.0 (0.3) 2.2 (0.4) 2.1 (0.4) 0.19
Interleukin-6 (pg/mL) 2.0 (0.4) 1.9 (0.5) 1.9 (0.7) 0.82
TNF-alpha (pg/mL) 2.3 (0.7) 2.5 (0.6) 2.3 (0.9) 0.51
CRP (mg/L) 1.9 (0.7) 1.1 (1.1) 0.9 (0.9) 0.01
PAI1 (ng/mL) 2.8 (1.1) 2.8 (0.7) 2.8 (0.9) 0.98
ICAM (ng/mL) 5.6 (0.1) 5.5 (0.2) 5.6 (0.3) 0.71
Diet composition (% of energy)
(Continued)
Macronutrient Composition andWeight Change in Obese Adolescents
PLOS ONE | DOI:10.1371/journal.pone.0151787 March 29, 2016 9 / 16
can be viewed in terms of what can be optimally expected of a dietary intervention using nor-
mal food and are comparable with a 2012 meta-analysis by Ho et al. [31] which showed the
mean effect of 33 lifestyle interventions was a BMI z-score reduction of -0.10 (95%CI -0.18 to
-0.02).
Given the severity of the obesity in these young people, we wished to ascertain whether a
moderate reduction in carbohydrate with a higher protein intake could be as effective as a low
fat eating pattern. Our results concur with the report by Demol. et al. [32] that suggest that
both SMC and SLF diets result in similar reductions in biochemical indices of cardiovascular
risk, at least in the short term. These data suggest that the rigid adoption of a low fat eating
regime is not necessarily the only dietary pattern that could result in longer term cardiovascular
protection. Flexibility in terms of finding a reduced energy intake eating pattern that is the
most acceptable to the individual is appropriate. However, the rapid weight loss seen by using
very low carbohydrate or protein modified fasts was not experienced by our participants and as
such it provides evidence that a more severe carbohydrate restriction, at least in the initial
phases of a weight loss attempt, would be required. We demonstrate that a clinically relevant
reduction in adiposity can realistically be achieved in a group of obese youth presenting for
weight management at a specialist public children’s hospital. The upward weight trajectory of
the untreated control group strengthens the case that doing nothing is not an option.
This study contributes to the understanding of body composition alterations in adolescents
following energy restricted diets. Here we demonstrate a significant loss of body fat (3–4 per-
centage points) with concurrent preservation of lean tissue, the optimal outcome in body com-
position change during weight loss. Using the measurement of total body potassium, an
accurate measure of body cell mass independent of body water, we describe the relatively low
lean mass of all the participants at baseline. In adults, sarcopenia in the presence of obesity is
documented and its relationship with functional impairment and increased cardiovascular risk
is emerging [33, 34]. Consequently, the addition of resistance strength training to preserve lean
tissue further may well be of benefit and perhaps acceptable to teenagers, as it is in adults. This
highlights the critical need for any intervention to preserve lean mass whilst targeting a reduc-
tion in body fat but importantly that a moderate increase in protein as demonstrated here was
insufficient to completely preserve lean mass. Weight management programs aimed at children
Table 1. (Continued)
Control SLF SMC P-value
(n = 14) (n = 36) (n = 37)
Protein 18 (2.4) 17 (3.2) 17 (2.7) 0.90
Fat 35 (3.3) 37 (5.2) 36 (5.7) 0.43
Carbohydrate 47 (4.5) 46 (6.2) 47 (6.6) 0.62
Resting energy expenditure (kcal/day) 1958 (321) 1914 (383) 1889 (299) 0.81
Physical Activity Level (PAL) 1.3 (0.1) 1.4 (0.2) 1.4 (0.1) 0.11
ALT = Alanine transaminase; BCM = body cell mass from total body potassium; BIA = bioelectrical impedance analysis technique; CRP = C-reactive
protein; HDL = High-density lipoprotein; LDL = low-density lipoprotein; HOMA-IR = homeostasis model assessment-estimated insulin resistance;
ICAM = Intercellular Adhesion Molecule; PAI-1 = plasminogen activator inhibitor-1; SLF = Structured Low Fat diet; SMC = Structured Modiﬁed
Carbohydrate diet; VLDL = very low-density lipoprotein
a Continuous variables presented as mean (standard deviation)
b Categorical variables presented as frequency (percentage).
c Adipokines/cytokines were transformed using the natural logarithm before analysis.
doi:10.1371/journal.pone.0151787.t001
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should include body composition measurement to monitor the effect on body compartment
changes which are independent of shifts in body water and not rely solely on the relatively
anthropometric instruments [35].
The use of structure such as portion size control and managed eating episodes are crucial
elements of success in weight control. ‘Eat Smart’ was designed specifically for this difficult tar-
get group and their parents who wished to have a system that would enable them to plan
together for meals and snacks with some flexibility but with clear limits. This technique also
assists the health care professional in monitoring adherence to goals [36]. The reduction in the
indicators of the metabolic syndrome at the end of the study period confirms that improve-
ment in weight status can produce meaningful reduction in cardiovascular risk factors, but
Table 2. Anthropometric, body and diet composition at end of intervention (n = 79). Between-diet group differences calculated using linear regression
with adjustment of value of outcome at baseline.a,b
Control SLF SMC Control vs. SLF Control vs. SMC SLF vs. SMC
(n = 14) (n = 32) (n = 33)
Mean (SD) Mean (SD) Mean (SD) P-value MD (95%CI); P MD (95%CI); P MD (95%CI); P
BMI z-score 2.29 (0.42) 2.10 (0.46) 2.05 (0.41) <0.001 -0.13 (-0.18, -0.07);
<0.001
-0.14 (-0.19, -0.09);
<0.001
-0.00 (-0.05,
0.04);0.83
Weight z-score 2.52 (0.75) 2.32 (0.70) 2.25 (0.55) <0.001 -0.15 (-0.21, -0.10);
<0.001
-0.17 (-0.24, -0.09);
<0.001
-0.01 (-0.06,
0.05);0.83
Height z-score 0.88 (0.90) 1.04 (1.08) 1.00 (1.09) 0.22 -0.05 (-0.11, 0.02); -0.01 (-0.08, 0.06); 0.04 (-0.01, 0.10);
0.14 0.83 0.15
% body fat (BIA) 42.98 (4.26) 39.54 (5.22) 38.21 (5.26) 0.01 -2.99 (-5.50, -0.48); -3.89 (-6.72, -1.06); -0.77 (-2.65, 1.11);
0.02 0.008 0.42
BCM/ Height z-score -0.86 (0.80) -0.79 (0.93) -0.54 (1.15) 0.58 0.20 (-0.28, 0.69); 0.19 (-0.23, 0.61); -0.05 (-0.38, 0.28);
0.41 0.37 0.77
BMI (kg/m2) 35.74 (8.66) 31.88 (6.17) 30.82 (4.85) <0.001 -1.58 (-2.06, -1.11); -1.75 (-2.43, -1.07); -0.15 (-0.66, 0.35);
<0.001 <0.001 0.54
Weight (kg) 96.88
(31.00)
86.26
(23.38)
83.03
(17.73)
<0.001 -4.15 (-5.50, -2.81); -4.51 (-6.41, -2.60); -0.22 (-1.62, 1.19);
<0.001 <0.001 0.76
Height (cm) 163.50
(8.45)
163.46
(11.40)
163.55
(11.36)
0.44 -0.03 (-0.56, 0.49); 0.25 (-0.38, 0.89); 0.28 (-0.21, 0.78);
0.90 0.43 0.25
Waist circumference
(cm)
113.26
(19.54)
102.88
(14.96)
101.48
(12.03)
0.005 -3.07 (-4.54, -1.61); -3.74 (-6.29, -1.19); -0.19 (-1.98, 1.60);
<0.001 0.005 0.83
Waist:Height ratio 0.69 (0.10) 0.63 (0.08) 0.62 (0.07) 0.005 -0.02 (-0.03, -0.01); -0.02 (-0.04, -0.01); -0.00 (-0.01, 0.01);
<0.001 0.006 0.75
Protein (%E) 20.0 (3.0) 21.5 (4.5) 24.1 (5.3) 0.04 1.6 (-2.1, 5.4); 0.38 5.1 (0.5, 9.7); 0.03 3.6 (0.5, 6.7); 0.02
Fat (%E) 37.1 (4.7) 31.9 (5.9) 36.9 (6.7) 0.14 -5.7 (-11.3, 0.0); 0.05 -1.4 (-6.9, 4.1); 0.60 4.3 (0.3, 8.3); 0.04
Carbohydrate (%E) 42.9 (3.0) 46.6 (5.7) 39.0 (7.6) 0.04 4.1 (-0.8, 9.0); 0.10 -3.3 (-9.4, 2.7); 0.27 -7.7 (-11.9, -3.6);
0.01
BCM = body cell mass from total body potassium; BIA = bioelectrical impedance analysis; E = energy; SLF = Structured low fat diet; SMC = Structured
modiﬁed carbohydrate diet
a Between-diet group differences presented as mean difference (MD); (95% Conﬁdence Interval); P-value.
b Number of paired measurements analyzed for control group, n = 14, except BCM/ Height z-score (n = 13), diet composition outcomes (n = 6); for SLF
group, n = 32 except except BCM/ Height z-score (n = 29), diet composition outcomes (n = 19); for SMC group n = 33, except diet composition outcomes
(n = 17).
doi:10.1371/journal.pone.0151787.t002
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Table 3. Biochemistry and energy expenditure at end of intervention (n = 79). Between-diet group differences calculated using linear regression with
adjustment for value of outcome at baseline. a,b
Control SLF SMC Control vs. SLF Control vs. SMC SLF vs. SMC
(n = 14) (n = 32) (n = 33)
Mean
(SD)
Mean
(SD)
Mean
(SD)
P-value MD (95%CI); P MD (95%CI); P MD (95%CI); P
HOMA IR 2.7 (1.1) 1.5 (0.9) 1.6 (0.9) 0.03 -0.7 (-1.2, -0.2);
0.009
-0.7 (-1.3, -0.2); 0.01 0.0 (-0.3, 0.4);
0.79
Cholesterol
Total (mmol/L) 4.4 (1.1) 4.2 (0.7) 4.2 (0.8) 0.20 -0.2 (-0.5, 0.0); 0.06 -0.2 (-0.5, 0.1); 0.30 0.1 (-0.1, 0.2);
0.40
HDL (mmol/L) 1.1 (0.4) 1.0 (0.2) 1.0 (0.2) 0.20 -0.1 (-0.2, 0.0); 0.16 0.0 (-0.1, 0.1); 0.71 0.1 (0.0, 0.1); 0.15
LDL (mmol/L) 2.8 (0.9) 2.6 (0.6) 2.6 (0.7) 0.58 -0.1 (-0.3, 0.1); 0.28 -0.1 (-0.4, 0.2); 0.49 0.0 (-0.1, 0.2);
0.74
VLDL (mmol/L) 0.5 (0.2) 0.5 (0.2) 0.5 (0.3) 0.46 0.1 (0.0, 0.1); 0.27 0.0 (-0.1, 0.1); 0.94 0.0 (-0.1, 0.0);
0.27
Triglycerides (mmol/L) 1.2 (0.7) 1.2 (0.4) 1.2 (0.5) 0.84 0.1 (-0.1, 0.3); 0.60 0.0 (-0.3, 0.3); 0.98 0.0 (-0.2, 0.1);
0.58
Liver function
ALT (U/L) 26.0 (8.1) 27.0
(14.5)
23.9
(15.5)
0.75 1.8 (-6.9, 10.4); 0.69 -0.2 (-8.7, 8.3); 0.96 -2.0 (-7.9, 3.9);
0.50
Adipokines/cytokinesc
Leptin (ng/mL) 4.1 (0.5) 3.6 (0.7) 3.5 (0.7) 0.004 -0.4 (-0.7, -0.2);
0.001
-0.4 (-0.7, -0.1);
0.005
0.0 (-0.2, 0.2);
0.75
Resistin (ng/mL) 2.6 (1.0) 2.2 (0.6) 2.2 (0.5) 0.49 -0.2 (-0.7, 0.2); 0.35 -0.2 (-0.6, 0.2); 0.36 0.0 (-0.2, 0.2);
0.99
Adiponectin (ng/mL) 2.0 (0.2) 2.2 (0.4) 2.2 (0.4) 0.09 0.1 (-0.1, 0.2); 0.33 0.1 (0.0, 0.3); 0.04 0.1 (0.0, 0.2); 0.13
Interleukin-6 (pg/mL) 1.8 (0.5) 1.7 (0.6) 1.7 (0.8) 0.76 0.0 (-0.3, 0.3); 0.97 -0.1 (-0.4, 0.3); 0.76 -0.1 (-0.4, 0.2);
0.47
TNF-alpha (pg/mL) 2.5 (1.1) 2.3 (0.6) 2.3 (0.8) 0.36 -0.3 (-0.8, 0.2); 0.22 -0.2 (-0.7, 0.3); 0.43 0.1 (-0.1, 0.3);
0.37
CRP (mg/L) 1.6 (1.2) 0.9 (0.9) 0.8 (1.0) 0.55 -0.3 (-1.0, 0.2); 0.24 -0.3 (-1.1, 0.5); 0.43 0.1 (-0.3, 0.4);
0.72
PAI-1 (ng/mL) 3.0 (0.9) 2.8 (0.8) 2.8 (0.8) 0.93 0.0 (-0.4, 0.4); 0.99 -0.1 (-0.5, 0.3); 0.70 0.0 (-0.3, 0.2);
0.74
ICAM (ng/mL) 5.3 (0.8) 5.4 (0.2) 5.6 (0.2) 0.09 0.2 (-0.1, 0.5); 0.19 (-0.1, 0.6); 0.10 0.1 (0.0, 0.2); 0.01
Resting energy expenditure (kcal/d) 2011
(361)
1852
(403)
1893
(333)
0.17 -132 (-237, -28);
0.01
-12 (-129, 106); 0.84 116 (25, 208);
0.01
Physical activity level 1.4 (0.2) 1.4 (0.1) 1.5 (0.1) 0.25 0.0 (-0.1, 0.1); 0.78 0.0 (-0.1, 0.1); 0.90 0.0 (-0.1, 0.1);
0.67
ALT = Alanine transaminase; BCM = body cell mass from total body potassium; BIA = bioelectrical impedance analysis technique; CRP = C-reactive
protein; HDL = High-density lipoprotein; LDL = low-density lipoprotein; HOMA-IR = homeostasis model assessment-estimated insulin resistance;
ICAM = Intercellular Adhesion Molecule; PAI-1 = plasminogen activator inhibitor-1; SLF = Structured Low Fat diet; SMC = Structured Modiﬁed
Carbohydrate diet; VLDL = very low-density lipoprotein
a Between-diet group differences presented as mean difference (MD); (95% Conﬁdence Interval); P-value.
b Number of paired measurements analyzed for control group, n = 14, except HOMA IR (n = 12), all cholesterol outcomes (n = 12), triglycerides (n = 12),
liver function (n = 11), adipokines/cytokines except ICAM (n = 12), ICAM (n = 9), physical activity level (n = 6); for SLF group, n = 32 except ICAM
(n = 23), physical activity level (n = 19); for SMC group n = 33, except HOMA IR (n = 32), all cholesterol outcomes (n = 32), triglycerides (n = 32), liver
function (n = 31), adipokines/cytokines except ICAM (n = 32), ICAM (n = 24), physical activity level (n = 20)
cAdipokines/cytokines were transformed using the natural logarithm before analysis.
doi:10.1371/journal.pone.0151787.t003
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clearly some require more intensive intervention or further weight loss to reduce their blood
pressure to acceptable levels. There was no evidence that the relative increase in dietary fat
experienced as a result of reducing carbohydrates had any adverse effect on inflammatory
markers which may be mediated by weight and body fat changes. Loss of body fat is the likely
facilitator of the significant drop in leptin in the active groups compared to control. Overall,
the metabolic impact of such dietary modifications was not profound although the study was
not powered to detect small differences in these parameters.
Treatment of childhood obesity has been described as complex and fraught with difficul-
ties [37]. ‘Eat Smart’ used a preparatory psychological group program, FRIENDS for lifeTM,
to ensure that all of those randomized did not meet clinical criteria for anxiety, depression
and disordered eating, common problems that we and others have identified in the obese
child although not often addressed prior to intervention [17, 38]. All randomized partici-
pants received advice and support in behaviour change processes prior to beginning their
weight management journey. This unique step may have contributed to our low attrition
rate (Fig 1). The higher proportion of predominately Caucasian girls (69%), living in lower
socio-demographic areas situates this study group for the purposes of generalizability. A
paper which is a reflective analysis of completers across the ‘Eat Smart’ studies characterised
what factors were predictive of successful weight loss and demonstrated that those who were
most successful were those enjoying higher social advantage and presenting with a lower
BMI [39].
Strengths and Limitations
The evaluation of these two structured diets has a number of strengths that include the use of
a control group and the successful completion of psychological preparedness program,
which ensured that all randomized participants were similarly ready to adopt lifestyle
change. The dietary patterns tested were piloted for feasibility and acceptability in young
people which resulted in two different macronutrient profiles and therefore all 3 macronutri-
ents being different in both intervention groups. The protocol of intensive follow up and die-
tician debriefing sessions along with a structured portion control system was designed to
maintain consistency of the dietary components. The imprecision of dietary measures and
accuracy of reporting, issues for most diet related interventions, must be acknowledged as a
limitation. We report energy-adjusted nutrients to reduce measurement error as it removes
extraneous variation that results from populations, such as adolescents, where differences in
individual energy requirements, due to their different body sizes and physical activity levels
are inevitable [40]. Also the short term intervention period must be regarded as a limitation.
Obviously longer term follow up is needed to establish if food choices are maintained over
time, however, we accept that after 12 weeks, as in adults [40, 41], weight loss has most likely
peaked and longer duration of intensive lifestyle only advice may offer little additive benefit
for weight change [4].
Conclusion
The burgeoning issue of adolescent obesity requires availability of effective treatment options
that are acceptable to both the adolescent and their caregivers. This study demonstrates that
macronutrients may not be as critical as methodologies that control overall energy intake, thus
supporting the impact that more individualization and tailoring of dietary prescription for
young people seeking weight management can be recommended which should increase com-
pliance in the longer term.
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